Northern Ireland Healthcare
Latest News
Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®▼ (fremanezumab)
TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Europe BV an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the National Institute for [...]
Shionogi Announces Launch of Mulpleo® (lusutrombopag) in the UK, for the Treatment of Severe Thrombocytopenia in Adult Patients With Chronic Liver Disease Undergoing Invasive Procedures
Mulpleo (lusutrombopag) is the first licensed treatment now available through the National Health Service (NHS) in the UK to treat severe thrombocytopenia in adults with [...]
Vertex Confirms Wales Offer Accepted for Access to All Licensed Cystic Fibrosis Medicines
-Eligible patients in Wales will soon have access to ORKAMBI® (lumacaftor/ivacaftor) and SYMKEVI® (tezacaftor/ivacaftor), expanded access to KALYDECO® (ivacaftor) under same terms as NHS England [...]
